- Filed
- May 8, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $613.7M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $1.82B |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $19.78B |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $19.88B |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $7B |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $8.02B |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $35.72B |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $36.72B |
| Current Assets | Q1 2024 · Mar 31, 2024 | $3.12B |
| Current Assets | Q1 2024 · Dec 31, 2023 | $4.89B |
| Total Assets | Q1 2024 · Mar 31, 2024 | $55.56B |
| Total Assets | Q1 2024 · Dec 31, 2023 | $57.11B |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 307.41K sh |
| Capex restated | Q1 2024 · Mar 31, 2023 | $766.28M |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2023 | $789.95M |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | $0.82 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | $0.94 |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $700.77M |
| Rd Expense restated | Q1 2024 · Mar 31, 2023 | $28M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | $353.34M |
| Revenue restated | Q1 2024 · Mar 31, 2023 | $4.39B |